Panel discussion

Syneos Health

Date:April 22, 2024
Room:Marriott Hotel

Panel title

Seeking payer-relevant input into your development plan: Focus the development effort to maximize commercial potential

Panel summary

A strong scientific case is not enough. Maximizing commercial potential starts early and needs to be an integral part of successful development. Yet, many biotechs start (too) late. Explore strategies for efficient and effective development, enhancing asset value by integrating payer-relevant input. Gain insights from industry leaders and healthcare payers as they discuss ways to refine your approach and demonstrate value that convinces payers and investors.

Speaker information


Prateet Minhas, Managing Director, Syneos Health Consulting


Laurent Massuyeau, CEO & Founder, IQone Healthcare
Marina Faiella, Head Forecasting & Analytics, BeiGene
Mathias Flume, Head of Department, Kassenärztliche Vereinigung

Company profile

Syneos Health Consulting uniquely delivers innovative solutions underpinned by clinical and commercial data-driven insights to address complex customer needs.
As science becomes increasingly complex, Syneos Health offers a portfolio of integrated solutions – from clinical trials through commercialization – to help biopharma accelerate life changing therapies for patients worldwide.